232 related articles for article (PubMed ID: 22490761)
1. No significant improvement of cardiovascular disease risk indicators by a lifestyle intervention in people with familial hypercholesterolemia compared to usual care: results of a randomised controlled trial.
Broekhuizen K; van Poppel MN; Koppes LL; Kindt I; Brug J; van Mechelen W
BMC Res Notes; 2012 Jul; 5():181. PubMed ID: 22490761
[TBL] [Abstract][Full Text] [Related]
2. A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with Familial Hypercholesterolemia (FH): design of the PRO-FIT randomised controlled trial.
Broekhuizen K; van Poppel MN; Koppes LL; Brug J; van Mechelen W
BMC Public Health; 2010 Feb; 10():69. PubMed ID: 20156339
[TBL] [Abstract][Full Text] [Related]
3. Effects of lifestyle intervention improve cardiovascular disease risk factors in community-based menopausal transition and early postmenopausal women in China.
Wu L; Chen R; Ma D; Zhang S; Walton-Moss B; He Z
Menopause; 2014 Dec; 21(12):1263-8. PubMed ID: 24781851
[TBL] [Abstract][Full Text] [Related]
4. Can multiple lifestyle behaviours be improved in people with familial hypercholesterolemia? Results of a parallel randomised controlled trial.
Broekhuizen K; van Poppel MN; Koppes LL; Kindt I; Brug J; van Mechelen W
PLoS One; 2012; 7(12):e50032. PubMed ID: 23251355
[TBL] [Abstract][Full Text] [Related]
5. Is the process of delivery of an individually tailored lifestyle intervention associated with improvements in LDL cholesterol and multiple lifestyle behaviours in people with familial hypercholesterolemia?
Broekhuizen K; Jelsma JG; van Poppel MN; Koppes LL; Brug J; van Mechelen W
BMC Public Health; 2012 May; 12():348. PubMed ID: 22583789
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Effectiveness of Individually Tailored Lifestyle Intervention in Patients With Familial Hypercholesterolemia.
Beyece İncazli S; Özer S; Kayikçioğlu M
J Cardiovasc Nurs; 2022 Sep-Oct 01; 37(5):465-474. PubMed ID: 35952313
[TBL] [Abstract][Full Text] [Related]
7. The effect of a comprehensive lifestyle intervention on cardiovascular risk factors in pharmacologically treated patients with stable cardiovascular disease compared to usual care: a randomised controlled trial.
Ijzelenberg W; Hellemans IM; van Tulder MW; Heymans MW; Rauwerda JA; van Rossum AC; Seidell JC
BMC Cardiovasc Disord; 2012 Sep; 12():71. PubMed ID: 22962863
[TBL] [Abstract][Full Text] [Related]
8. High-soluble-fiber foods in conjunction with a telephone-based, personalized behavior change support service result in favorable changes in lipids and lifestyles after 7 weeks.
Kris-Etherton PM; Taylor DS; Smiciklas-Wright H; Mitchell DC; Bekhuis TC; Olson BH; Slonim AB
J Am Diet Assoc; 2002 Apr; 102(4):503-10. PubMed ID: 11985406
[TBL] [Abstract][Full Text] [Related]
9. Effect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysis.
Zhang X; Devlin HM; Smith B; Imperatore G; Thomas W; Lobelo F; Ali MK; Norris K; Gruss S; Bardenheier B; Cho P; Garcia de Quevedo I; Mudaliar U; Jones CD; Durthaler JM; Saaddine J; Geiss LS; Gregg EW
PLoS One; 2017; 12(5):e0176436. PubMed ID: 28493887
[TBL] [Abstract][Full Text] [Related]
10. Effect of lifestyle intervention on cardiometabolic risk factors: results of the POWER-UP trial.
Vetter ML; Wadden TA; Chittams J; Diewald LK; Panigrahi E; Volger S; Sarwer DB; Moore RH;
Int J Obes (Lond); 2013 Aug; 37 Suppl 1(0 1):S19-24. PubMed ID: 23921777
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.
; Wing RR
Arch Intern Med; 2010 Sep; 170(17):1566-75. PubMed ID: 20876408
[TBL] [Abstract][Full Text] [Related]
12. Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia.
Ravnskov U; de Lorgeril M; Kendrick M; Diamond DM
Med Hypotheses; 2018 Dec; 121():60-63. PubMed ID: 30396495
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk factor profiles in familial hypercholesterolemia patients with and without genetic mutation compared to a nationally representative sample of adults in a high-risk European country.
Chlebus K; Zdrojewski T; Gruchała M; Gałąska R; Pajkowski M; Kocejko MR; Chmara M; Pencina MJ
Am Heart J; 2019 Dec; 218():32-45. PubMed ID: 31706143
[TBL] [Abstract][Full Text] [Related]
14. Family-centered brief intervention for reducing obesity and cardiovascular disease risk: A randomized controlled trial.
Duncan S; Goodyear-Smith F; McPhee J; Zinn C; Grøntved A; Schofield G
Obesity (Silver Spring); 2016 Nov; 24(11):2311-2318. PubMed ID: 27616217
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of multidisciplinary patient counselling in reducing cardiovascular disease risk factors through nonpharmacological intervention: results from the Healthy Heart Program.
Simpson DR; Dixon BG; Bolli P;
Can J Cardiol; 2004 Feb; 20(2):177-86. PubMed ID: 15010741
[TBL] [Abstract][Full Text] [Related]
16. Effect of an intervention to improve the cardiovascular health of family members of patients with coronary artery disease: a randomized trial.
Reid RD; McDonnell LA; Riley DL; Mark AE; Mosca L; Beaton L; Papadakis S; Blanchard CM; Mochari-Greenberger H; O'Farrell P; Wells GA; Slovinec D'Angelo ME; Pipe AL
CMAJ; 2014 Jan; 186(1):23-30. PubMed ID: 24246588
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
[TBL] [Abstract][Full Text] [Related]
19. An economic evaluation alongside a randomized controlled trial evaluating an individually tailored lifestyle intervention compared with usual care in people with familial hypercholesterolemia.
Broekhuizen K; van Wier MF; Koppes LL; Brug J; van Mechelen W; Bosmans JE; van Poppel MN
BMC Res Notes; 2015 Jul; 8():317. PubMed ID: 26219281
[TBL] [Abstract][Full Text] [Related]
20. Combined Before-and-After Workplace Intervention to Promote Healthy Lifestyles in Healthcare Workers (STI-VI Study): Short-Term Assessment.
Scapellato ML; Comiati V; Buja A; Buttignol G; Valentini R; Burati V; La Serra L; Maccà I; Mason P; Scopa P; Volpin A; Trevisan A; Spinella P
Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30235849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
